Li He
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
- Gout, Hyperuricemia, Uric Acid
-
- MicroRNA in disease regulation
Papers in
- Nephrology 12
- Chronic Kidney Disease and Diabetes 6
- Gout, Hyperuricemia, Uric Acid 3
- Renal Diseases and Glomerulopathies 3
-
- Inflammasome and immune disorders 3
- Co-authors
- Niansong Wang (14 shared papers)Ying Fan (14 shared papers)Jiejun Wen (8 shared papers)Joel D. Schilling (4 shared papers)Qunzi Zhang (9 shared papers)Yuqiao Chang (2 shared papers)Zhikun Guo (1 shared paper)John Cijiang He (5 shared papers)
- Journals
- Cellular Physiology and Biochemistry (4 papers)Environmental Science and Pollution Research (2 papers)Nutrients (2 papers)Clinical Interventions in Aging (2 papers)Environmental Research (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Li He
52 papers receiving 1.3k citations
Li He's Hit Papers
Peers
Comparison fields: 5 of 128
- Nephrology 242
- Cancer Research 103
- Immunology 145
- Cell Biology 105
- Molecular Biology 437
Countries citing papers authored by Li He
This map shows the geographic impact of Li He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li He more than expected).
Fields of papers citing papers by Li He
This network shows the impact of papers produced by Li He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li He. The network helps show where Li He may publish in the future.
Co-authors
The 25 scholars most cited alongside Li He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer Hit paper breakdown → | 2022 | 171 |
| 2 | 2019 | 113 | |
| 3 | 2019 | 108 | |
| 4 | 2017 | 61 | |
| 5 | 2014 | 61 | |
| 6 | 2012 | 54 | |
| 7 | 2018 | 47 | |
| 8 | 2017 | 46 | |
| 9 | 2016 | 44 | |
| 10 | 2017 | 41 | |
| 11 | 2017 | 40 | |
| 12 | 2022 | 36 | |
| 13 | 2006 | 35 | |
| 14 | 2016 | 31 | |
| 15 | 2020 | 28 | |
| 16 | 2018 | 27 | |
| 17 | 2020 | 25 | |
| 18 | 2023 | 24 | |
| 19 | 2018 | 24 | |
| 20 | 2023 | 23 |
About Li He
Li He is a scholar working on Nephrology, Molecular Biology, Health, Toxicology and Mutagenesis, Surgery and Pathology and Forensic Medicine, having authored 53 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (6 papers), Climate Change and Health Impacts (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Inflammasome and immune disorders (3 papers), Renal Diseases and Glomerulopathies (3 papers), Biomedical Research and Pathophysiology (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Nephrology (242 citations), Cancer Research (103 citations), Immunology (145 citations), Cell Biology (105 citations) and Molecular Biology (437 citations). Li He has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Niansong Wang, Ying Fan, Jiejun Wen, Joel D. Schilling, Qunzi Zhang, Yuqiao Chang, Zhikun Guo, John Cijiang He, Qianqian Guo and Liting Wang. Their work appears in journals such as Cellular Physiology and Biochemistry, Environmental Science and Pollution Research, Nutrients, Clinical Interventions in Aging and Environmental Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.